Barbie Taylor‐Harding

Author

University of California, Los Angeles

Also Known As

B Taylor-Harding, B. Taylor-Harding, Barbie Taylor-Harding, Barbie Taylor‐Harding

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Cedars-Sinai Medical Center Massachusetts General Hospital Cancer Research Institute Center for Cancer Research

About

Barbie Taylor‐Harding is an author at University of California, Los Angeles specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	612
2	Cell Biology	4	4	541
3	Engineering	1	1	130
4	Health Sciences	1	1	71
5	Molecular Genetics	1	1	77

Barbie Taylor‐Harding

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Native E2F/RBF Complexes Contain Myb-Interacting Proteins and Repress Transcription of Developmentally Controlled E2F Target Genes Michael Korenjak, Barbie Taylor‐Harding, Ulrich K. Binné, Cell Developmental BiologyGene RegulationRepress TranscriptionGene Regulatory NetworkTranscription Factors	2004	284
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets Dongyu Jia, Zhenqiu Liu, Nan Deng, Cancer Letters OncologyEngineeringMedicineTherapeutic TargetsRational Therapy	2016	130
VEGFR3 Inhibition Chemosensitizes Ovarian Cancer Stemlike Cells through Down-Regulation of BRCA1 and BRCA2 Jae Young Lim, Kun Yang, Barbie Taylor‐Harding, Neoplasia	2014	129
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS Barbie Taylor‐Harding, Paul‐Joseph Aspuria, Hasmik Agadjanian, Oncotarget	2014	118
Drosophila E2F1 Has Context-Specific Pro- and Antiapoptotic Properties during Development Nam-Sung Moon, Maxim V. Frolov, Eun-Jeong Kwon, Developmental Cell Developmental BiologyGeneticsGenomic MechanismCell DeathAntiapoptotic Properties	2005	77
Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein Daniel R. Scoles, Xuan Xu, Haimei Wang, Gynecologic Oncology OxysterolMedicineLiver PhysiologyHormonal ReceptorOvarian Carcinoma Cells	2009	71
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with <scp>PARP</scp> inhibitors Álvaro Lahiguera, Petra Hyroššová, Diana Garzón, EMBO Molecular Medicine	2020	69
p55, the <i>Drosophila</i> Ortholog of RbAp46/RbAp48, Is Required for the Repression of dE2F2/RBF-Regulated Genes Barbie Taylor‐Harding, Ulrich K. Binné, Michael Korenjak, Molecular and Cellular Biology	2004	68
Screening cell mechanotype by parallel microfiltration Dongping Qi, Navjot Kaur Gill, Chintda Santiskulvong, Scientific Reports	2015	56
Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells Barbie Taylor‐Harding, Sandra Oršulić, Beth Y. Karlan, Gynecologic Oncology Demonstrate Synergistic CytotoxicityMedicinePharmacologyCancer BiologyAnti-cancer Agent	2010	50

Page 1